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Abstract
Background: Non cephalic presentation in childbirth involves various risks to both the mother and the foetus. The incidence
in Spain is 3.8% of all full-term pregnancies. The most common technique used to end the gestation in cases of non cephalic
presentation is that of caesarian section, and although it provokes a lower rate of morbi-mortality than does vaginal delivery in
such situations, there remains the possibility of traumatic injury to the foetal head and neck, while maternal morbidity is also
increased. The application of heat (moxibustion) to an acupuncture point, in order to correct non cephalic presentation, has
been practised in China since ancient times, but as yet there is insufficient evidence of its real effectiveness.
Methods/Design: The experimental design consists of a multi-centre randomised controlled trial with three parallel arms, used
to compare real moxibustion, sham moxibustion and the natural course of events, among pregnant women with a non cephalic
presentation and a gestational duration of 33–35 weeks (estimated by echography). The participants in the trial will be blinded
to both interventions. The results obtained will be analyzed by professionals, blinded with respect to the allocation to the
different types of intervention. In addition, we intend to carry out a economic analysis.
Discussion: This trial will contribute to the development of evidence concerning moxibustion in the correction of non cephalic
presentations. The primary outcome variable is the proportion of cephalic presentations at term. As secondary outcomes, we
will evaluate the proportion of cephalic presentations at week 38 of gestation, determined by echography, together with the
safety of the technique, the specificity of moxibustion and the control of the blinding process.
This study has been funded by the Health Ministry of the Andalusian Regional Government.
Trial registration: Current Controlled Trials ISRCTN10634508.
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Background
Non cephalic presentation (NCP) in childbirth involves
various risks to both the mother and the foetus. NCP
includes breech, oblique and transverse presentations.
The incidence of breech presentation (BP) is 20% at 28
weeks' gestation, although spontaneous version tends to
occur more frequently [1], such that in only 3–4% of
women with a full-term pregnancy is the foetus BP [2]; in
Spain, NCP represents 3.8% of all births [3].
Until week 28–32, and under normal conditions, the foe-
tus has a high degree of mobility, and remains in an unsta-
ble situation. From the latter date, the foetus adapts itself
to the shape of the uterus, adopting a head-down posture,
and normally remains so until birth. There are various rea-
sons that may prevent the foetus from moving into the
cephalic position, the most common of which, according
to a specialized study [4] are: a) pre-term birth; this factor
is more influential with lower gestational ages (35%
before week 28, 16.8% from week 28–31, 8.9% from
week 32–36 and 3.7% from week 36–41); b) foetal mal-
formations (those most commonly related to NCP are
anencephaly, hydrocephaly, spina bifida, polycystic kid-
neys and Potter's Syndrome, as well as trisomies 13, 18
and 21; c) multiple pregnancy, in which the incidence of
NCP is 7 times greater than in the case of a singleton preg-
nancy. High levels of perinatal mortality and morbidity
are known to be associated with NCP, due mainly to pre-
maturity, congenital malformations, hypoxia or birth
trauma [5,6], and so a breech delivery is a birth that is cat-
egorized between dystocia and eutocia.
The most common technique used to end gestation in
cases of NCP is that of caesarian section. From the results
of the study by Hannah et al. [7], in October 2000, from
the results produced by the Term Breech Trial Collabora-
tive Group, and from the Cochrane Collaboration review
[8], we now know that foetuses which are extracted by
elective caesarian section have a lower level of perinatal
morbi-mortality than those delivered vaginally. However,
this technique does not prevent traumatic lesions to the
foetal head and neck and, moreover, it is associated with
an increase in maternal morbidity [8-11]. In addition to
the increase in morbidity immediately following a caesar-
ean section, there may occur other types of complications,
such as intraabdominal adhesions, with the possibility of
later infertility and risks in future pregnancies caused by
the uterine scar [11].
Due to the risks arising both in breech presentation and
from a caesarean section, various manoeuvres have been
suggested over the years to promote spontaneous cephalic
version of the foetus during the final two months of the
pregnancy. Of these actions, the most commonly adopted
is that of external cephalic version (ECV), which can be
performed either between week 32–34 of gestation, or
after week 37. A Cochrane Review concluded that, in com-
parison with the non-performance of ECV, the latter tech-
nique, when begun pre-term, reduces NCP births, while,
in comparison with full-term ECV, beginning it between
week 34–35 may be of some benefit as concerns the
reduction of the rates of NCP and of caesarean section,
although further trials were recommended [8]. Other
types of manoeuvres and techniques have been tested,
with varying degrees of success, in order to increase foetal
mobility in a non-traumatic way.
Acupuncture and moxibustion are therapeutic techniques
found in traditional Chinese medicine. They have been
employed since ancient times, and specific recommenda-
tions in Chinese texts include the application of heat
(moxibustion) by the combustion of Artemisia vulgaris
(moxa) over an acupuncture point in order to correct NCP
[12,13]. This latter point, known as Zhiyin  (BL67) is
located in the outer corner of the little toenail. In addition
to moxibustion, acupuncture may also be used, either
alone or in association with moxibustion, on this or other
points, although it has been found that the highest level
of effectiveness is associated with the application of mox-
ibustion alone [14]. A Cochrane review [15] concluded
that there is insufficient evidence from the studies
included in its analysis, and observed that there have been
few well-designed studies (only 3 are included in the
review) and that most of them used a small sample. Some
studies with a larger sample, such as that by Kanakura et
al. [16], were not randomized. A larger, systematic review
that we have carried out this year (manuscript submitted
for publication), with the inclusion of new studies per-
formed to date, and with the incorporation of those pub-
lished in Chinese in the last 10 years, shows that studies
contain to be of low methodological quality. We estimate
a correction rate of 70% (versus 50% in control groups)
among pregnant women treated with moxibustion.
Among the studies carried out so far, no reports have been
made of side effects, although the smoke generated while
the moxa is burned may irritate the respiratory tracts. Nev-
ertheless, there is no evidence to support this hypothesis
[15]. Neri et al. [14,17] have made a cardiotocographic
study of the effects of moxibustion on foetal heartbeat,
and concluded that no harm is caused by this process.
The present study is funded by the Health Ministry of the
Andalusian Regional Government (Project No. 0053/
2007).
Methods
Research aims and questions
The aim of this study is to assess the effects of sensorial
stimulation with moxibustion in the outer corner of theBMC Complementary and Alternative Medicine 2008, 8:22 http://www.biomedcentral.com/1472-6882/8/22
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little toenail (BL67) in order to produce version in non-
cephalic presentations.
Research questions are
How effective is moxibustion at point BL67 in terms of the
rate of full-term cephalic presentations?
How effective is moxibustion at point BL67 in terms of the
rate of caesarean sections?
What is the effect of moxibustion at a non-specific point
such as SP1 in pregnancies with NCP?
To what extent are the pregnant women to whom the
study techniques are applied confident of the outcome?
How safe is the technique in terms of increased rates of
changed foetal cardiac rhythm, the risk of premature
birth, and changes in APGAR scores at 1 minute and at 5
minutes?
What is the cost-effectiveness of treatment with moxibus-
tion for cases of NCP?
Duration of Study
April 2008 to December 2010
Subjects
Pregnant women recruited by their obstetrician during the
third scheduled echography (at week 32 of gestation),
after confirmation of NCP. These pregnant women will be
referred to midwives at the participating Primary Health-
care Clinics belonging to the Andalusian Public Health
System in the provinces of Sevilla, Huelva, Cádiz and
Málaga. The pregnant women will be informed as follows:
"If you decide to take part in the study, in addition to
being given various postural recommendations, you will
be included, at random, in one of the three treatment
groups. In two of these, moxibustion techniques will be
applied at a specific point on each foot, while in the third
group the standard treatment procedures followed in the
healthcare system will be applied, to see if spontaneous
correction occurs. If you are assigned to one of the two
groups in which moxibustion is applied, then, according
to the random choice made, you may be given moxibus-
tion at a point that has been proved to be effective, or on
the contrary, at a point that has not proved to be of any
value for the aims of our study". The pregnant women will
also be informed of the possible risks associated with the
use of moxibustion (respiratory discomfort from the
smoke inhaled, the possibility of burns or of ulceration of
the skin) and that they may conclude their participation
in the study at any time, with no type of penalty or loss of
benefits they would otherwise be entitled to.
The subjects included in the study will be pregnant
women, aged at least 18 years, whose foetus is in a non
cephalic position (diagnosed by physical examination
and by echography), with a gestational age of 33–35
weeks (estimated by echography), normal foetal biome-
try, who have signed their informed consent and who
have not previously received moxibustion treatment to
correct the position of their unborn baby. Criteria for
exclusion will include twin pregnancy, pelvic defect, pre-
vious uterine surgery, foetal malformation or chromo-
some disorder, uterine malformation, risk of premature
birth (preterm uterine contractions and/or initial dilation
or shortening of the cervix with a Bishop's score of 4),
uterine fibromas > 4 cm, treatment with tocolytic drugs,
heart or kidney disease affecting the mother, other preg-
nancy-related complications, or incapacity to complete
the questionnaire or respond to the assessor's questions.
The ethical validity of this study has been analysed and
approved by the Clinical Trials Ethics Committee of the
Andalusian Regional Government, following approval by
the corresponding Research Committee at each of the par-
ticipating clinics.
Randomization and treatment allocation
The randomization of the three branches of the study will
be carried out on a centralized basis, by a statistician who
is otherwise unrelated to the study, using a 1:1:1 scheme
in blocks of 12 and stratifying by clinics. There will be the
same number of sets of envelopes as there are of partici-
pating midwives/clinics (some 40 midwives are expected
to take part). Each set will contain 12 opaque envelopes
which will be sealed after the introduction of a card with
the letter corresponding to the allocation to the group as
determined by the software-generated sequence: Group A
(true moxibustion), Group B (sham moxibustion) and
Group C (control). After the baseline assessment and the
signing of informed consent, these sealed, opaque, num-
bered envelopes will be used in sequence to assign the
study subjects to one of the three groups. The collaborat-
ing midwife will note on the card the pregnant woman
number and that of the clinic. At the end of the study, the
chief researcher will check each card against the original
randomization list to confirm that all the subjects received
the treatment that had been assigned to them. This
method ensures that neither the clinics nor the healthcare
professionals taking part in the study will be involved in
the randomization process and thus will not be able to
influence it. A patient may be withdrawn from the study
at any time, at her discretion or that of the researcher. The
reasons for this will be noted down on the summary page
of the Data Collection Record (DCR). The midwives who
participate in the study have attended a 10-hour training
course on postural recommendations and moxibustionBMC Complementary and Alternative Medicine 2008, 8:22 http://www.biomedcentral.com/1472-6882/8/22
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techniques, and in which criteria for data collection were
standardised.
Sample size
The sample size has been predetermined at n = 492
patients, for a significance level of 95%, a power of 90%
and a difference in the success rates of either of the inter-
vention groups (A or B) with the control group (C) of
20%, assuming a dropout rate of 25%. These values were
calculated using SamplePower version 2 software.
Interventions
All the study subjects will be given various postural rec-
ommendations.
True moxibustion (TM): The first intervention will be
made at the Healthcare Clinic. This session (overseen by
the midwife responsible) will serve as a training session
for the friend or relative who is to apply the remaining ses-
sions, at home. The mother should lie down, face up,
wearing comfortable clothing and with no pressure at the
waist from buttons, belt, etc. and with her legs slightly
bent at the knee. Heat will be applied for 20 minutes, by
means of a moxa cone (herbal preparation with Artemisia
vulgaris) at point BL67 (Zhiyin), close to the outer angle of
the little toenail (Figure 1). The heat will be applied from
a distance of 1.5–3 cm, to ensure that the subject notices
a feeling of warmth in the zone, but without any pain or
burning. The application site (right or left foot) will be
alternated every 2 minutes or more often if any untoward
sensation of heat is felt.
False/Sham moxibustion (SM): This procedure will be
identical to that applied to the TM group except that the
point stimulated will be a non-active one – according to
the principles of Traditional Chinese Medicine, point SP1
(Yinbai), close to the inner angle of the big toenail (Figure
1).
Control group, under observation (CG): The subjects in
this group will receive the standard treatment, in accord-
ance with the Andalusian Healthcare System Treatment
Guide "Embarazo, parto y puerperio" (Pregnancy, birth and
childcare) (2nd edition).
Outcome measures
Primary outcome
The rate of cephalic presentation at term will be taken as
the primary endpoint variable.
Secondary outcomes
Secondary outcomes will include the rate of cephalic pres-
entation at week 38 of gestation (CP38) (determined by
echography) and the number of days of treatment
received until version occurs. The intervention allocation
to the moxibustion groups (true or sham) will be control-
led by asking the subject: "What type of treatment do you
think you received?" Three possible answers may be given:
A) Real; B) Sham; C) I don't know. The following sociode-
mographic covariables will be recorded: age, race, educa-
tional level, occupation, level of income, occupational
activity, weight (kg), height (cm). In addition, these
obstetric-gynaecological variables will be recorded: gesta-
tional age when subject was included in the study, deter-
mined by foetal biometry; type of presentation,
determined by echography (characterized as breech,
oblique or transverse presentation); foetal biometry
(biparietal diameter, abdominal diameter and length of
femur) [week of gestation when biometry is performed];
location of the placenta (categorized as anterolateral or
Acupuncture points used Figure 1
Acupuncture points used. Location of the two acupuncture points used in the study; Zhiyin BL67 for Group A and Yinbai 
SP1 for Group B.BMC Complementary and Alternative Medicine 2008, 8:22 http://www.biomedcentral.com/1472-6882/8/22
Page 5 of 8
(page number not for citation purposes)
posterior), parity (number of previous births), and previ-
ous miscarriages. The following security variables (in the
first session) will be used: maternal heartbeat prior to the
stimulus; foetal heartbeat prior to the stimulus; maternal
heartbeat at 5 minutes after the stimulus; foetal heartbeat
at 5 minutes after the stimulus. The security variables
determined during the treatment will be recorded on the
self-reported questionnaire which is completed by the
subjects after each home treatment session, with data on
foetal movements, uterine contractions, maternal heart-
beat and any other incident following the stimulation.
Finally, a number of other variables related to the birth
will be recorded, including gestational age at birth, weight
of the neonate, sex of the neonate, type of birth (vaginal
or caesarean section), and APGAR score at 1 and 5 min-
utes (Figure 2).
Data collection and analysis
Data collection
Most of the data obtained from the study will be recorded
in the Pregnant Woman's Health Passport and in the
Child's Health Passport. A Data Collection Record (DCR)
form will be designed, including the variables of interest
that will be noted down by the midwife collaborating
with the healthcare clinic. We have designed a self-
reported questionnaire for the subject to fill in after each
session (during the two weeks' duration of the treatment),
with data such as the number and intensity of foetal
movements, the uterine contractions, maternal heartbeat
and any relevant incidents that may have occurred follow-
ing the stimulation. This information will be codified and
sent weekly to a database for subsequent statistical analy-
sis.
The baseline and intermediate evaluations, together with
the results data obtained at birth, will be made by the cor-
responding midwife. The self-reported questionnaires will
be oriented by the same evaluating personnel. Collateral
effects and possible adverse reactions to the treatment will
also be noted.
Statistical analysis
In the first place, we will perform an analysis following
intention-to-treat principles, including all the subjects
with valid data, irrespective of whether or not they
received the treatment assigned. These results will be com-
pared with those obtained by an on treatment analysis, in
order to determine whether violations of the protocol led
to bias. The subjects for whom deviations from the proto-
col are observed – such as not having received the com-
plete treatment, or as having received insufficient follow
up, will be excluded from the per treatment analysis. A
comparison will be made of respondents and non-
respondents to reveal the existence of any selection or
classification bias.
Comparability between the interventions and usual care
groups will be assessed at baseline to evaluate the differ-
ences. The magnitude of the difference in any imbalance
produced by the random assignation to the groups will be
evaluated using means and proportions ratios (using that
of the usual care group as the reference level).
In the bivariate analysis of the magnitude of the associa-
tion between exposure and effect, diverse tests of statisti-
cal significance will be employed to make comparisons
between k samples (parametric or otherwise, depending
on the asymmetric or otherwise distribution of the results
variables and on the homogeneity of their variances), tak-
ing the usual care group as the reference level and using
comparison tests for differences in proportions in the pri-
mary outcome measure.
For the primary outcome variable, logistic regression
models will be created, using ITT analysis. These will
include, firstly, the group variables (experimental vs con-
trol), taking the control group (usual care) as the reference
level. Then, the model will be adjusted for the variables of
age, parity and weeks of gestation at randomization (the
baseline variables). Adjustment will also be made for
other possible confounders (the variables that are imbal-
anced in the baseline analysis) using criteria of statistical
significance (P < 0.05) and of confusion (change of over
10% according to the magnitude estimator – the inci-
dence odds ratio). The detection of possible interactions
with the "treatment group" variable will be carried out by
means of statistical significance criteria for the corre-
sponding terms of interaction, introducing the relevant
additive and multiplicative interaction variables. The level
of significance will be set at <0.05 α for the global com-
parisons, although this level will be penalized by the exist-
ence of an intermediate level, as explained below. A cost
effectiveness analysis, from the standpoint of the Andalu-
sian Public Healthcare System, will be performed.
Intermediate analysis
An intermediate analysis will be performed when the fol-
low up of half of the total sample has concluded and the
results of this are known, using multiple Bonferroni tests,
and establishing a level of statistical significance for 2 tests
at P < 0.025. This penalization is necessary to avoid exag-
geration of any type I error.
Discussion
As observed above, the problem identified by the analysts
of the only Cochrane review available is the low method-
ological quality of most of the studies that have been
made. In designing the present study, special care was
taken regarding the characteristics conforming a quality
RCT, in accordance with the recommendations made by
Jadad [18]. Nevertheless, the following foreseeable limita-BMC Complementary and Alternative Medicine 2008, 8:22 http://www.biomedcentral.com/1472-6882/8/22
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Flow diagram for the study Figure 2
Flow diagram for the study. Work scheme with description of assessment visits and times.BMC Complementary and Alternative Medicine 2008, 8:22 http://www.biomedcentral.com/1472-6882/8/22
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tions should be pointed out: firstly, the sample was
extracted from the universe of pregnancies managed
within the Andalusian Public Healthcare System (SSPA),
and therefore the conclusions drawn will only be applica-
ble to this population group. The complexity of including
private clinics in the study led us to renounce this idea,
especially in view of the fact that the coverage of the preg-
nancy control programme within the public system is
almost universal; moreover, the pregnant women who
make use of private systems do not stop receiving the fol-
low-up attention scheduled under the public healthcare
system. From the bibliographic review performed, neither
does it seem that social class influences the incidence of
breech presentation or its version during gestation. It is
very likely, therefore, that the results obtained will resem-
ble those that would be derived for the entire population
of pregnant women in Andalusia. The inclusion of a rou-
tine control of the official programme (an echography
performed in week 32) also avoids possible selection bias.
Thus, with the involvement of the gynaecologist perform-
ing this examination, and of the midwife who participates
in routine care, the uptake is ensured of 100% of the cases
of NCP detected during the study period, while the rate of
losses to follow up is minimised.
Secondly, there exists the possibility (which has actually
occurred in other studies) of a pregnant woman refusing
to take part when she discovers which branch of the
research study she has been assigned to. This is applicable
to the formation of the control group, as normally any
intervention (whether true or sham moxibustion) will be
willingly accepted by a pregnant woman in a situation of
some risk. In the studies examined, this has actually
occurred in only a very small percentage of cases, but note
should be taken of this possible source of bias.
Thirdly, in designing the present study, we decided upon
self-implementation of the intervention procedure, rather
than calling upon an expert in acupuncture to apply it.
The advantages of the latter approach are obvious: the cor-
rect implementation of the technique is guaranteed, it can
be suited to the characteristics of each subject and it is pos-
sible to detect possible intermediate effects of the proce-
dure, among other possibilities. However, the multicentre
nature of this study means that such an approach is
impractical. Thanks to the simplicity of the procedure, it
can be learned rapidly by persons who are sufficiently
motivated (which is indeed the case) and, in addition,
with a view to its possible generalized implementation, if
obvious benefits are thus gained, the design used is more
appropriate to the reality of the actual public healthcare
system.
Finally, it should be noted that we are investigating a
desirable final effect (foetal version) but not the mecha-
nisms by which it is achieved. Other studies have included
parameters related to possible increases in foetal move-
ments or to secondary neurohumoral changes following
the application of moxa to the Zhiyin BL67 point. This is
not the case or the aim of the present study; we believe
such an investigation would require an individualized
study design, distinct from that proposed in this paper.
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